Immunogenicity 15818
Sample ID
P04-CDC37L1-P186L
Response
Positive
Tumor Type
Melanoma
Gene Symbol
CDC37L1
Transcript ID
None
HLA INFO
A*02:01
TCR INFO
TRAJAJ13*02
TRBVBV4-1
TRBDBD2
TRBJBJ1-3
TRAVAV38-2
Full length protein sequence (337 aa)
MEQPW
1
PPPGP
6
WSLPR
11
AEGEA
16
EEESD
21
FDVFP
26
SSPRC
31
PQLPG
36
GGAQM
41
YSHGI
46
ELACQ
51
KQKEF
56
VKSSV
61
ACKWN
66
LAEAQ
71
QKLGS
76
LALHN
81
SESLD
86
QEHAK
91
AQTAV
96
SELRQ
101
REEEW
106
RQKEE
111
ALVQR
116
EKMCL
121
WSTDA
126
ISKDV
131
FNKSF
136
INQDK
141
RKDTE
146
DEDKS
151
ESFMQ
156
KYEQK
161
IRHFG
166
MLSRW
171
DDSQR
176
FLSDH
181
PYLVC
186
EETAK
191
YLILW
196
CFHLE
201
AEKKG
206
ALMEQ
211
IAHQA
216
VVMQF
221
IMEMA
226
KNCNV
231
DPRGC
236
FRLFF
241
QKAKA
246
EEEGY
251
FEAFK
256
NELEA
261
FKSRV
266
RLYSQ
271
SQSFQ
276
PMTVQ
281
NHVPH
286
SGVGS
291
IGLLE
296
SLPQN
301
PDYLQ
306
YSIST
311
ALCSL
316
NSVVH
321
KEDDE
326
PKMMD
331
TV
336
Mutation Information
DNA mutation:
None
Peptide Range:
181 ~ 189
Mut AA position:
186 (6 in Wild Type peptide)
Alignment
Wild Type:
"FLSDHPYLV
|||||.|||
Mutant:
FLSDHLYLV"
Nature, 2017
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancerGene Name (from Reference) CDC37L1
Checkpoint
Blockade
None
ACT
N
Vaccination
Y
Curative
Effect
Metastasis
minimal_peptide
Y
Antigen
Type
peptide
T-cell
Source
PBL
APC
Type
multimer
Assay
None